Financial Times: Get vaccine new variant ready

GreenLight Biosciences explain to the Financial Times how messenger RNA can help get the Covid-19 vaccine new variant ready.

GreenLight Biosciences spoke to the Financial Times about making sure that any vaccine is new variant ready for Covid-19. An extract from the article is below:

Andrey Zarur, chief executive of Greenlight Biosciences, a biotech company that is making a messenger RNA vaccine, said it made sense to design new vaccines to “prepare for further drift”.

“Then you have a better chance of your new vaccine continuing to protect against new variants,” Mr Zarur said.

Read the full article here.

Find out more about how GreenLight manufactures RNA here.